These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 17912460

  • 21. Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy.
    Eslahi NK, Muller S, Nguyen L, Wilson E, Thull N, Rolland A, Pericle F.
    Cancer Gene Ther; 2001 Jan; 8(1):55-62. PubMed ID: 11219494
    [Abstract] [Full Text] [Related]

  • 22. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
    Yang Q, Yang G, Wei L, Jia F, Wu M, Guo Y.
    Zhonghua Yi Xue Za Zhi; 2002 Jun 10; 82(11):775-9. PubMed ID: 12126551
    [Abstract] [Full Text] [Related]

  • 23. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination.
    Bramson JL, Hitt M, Gauldie J, Graham FL.
    Gene Ther; 1997 Oct 10; 4(10):1069-76. PubMed ID: 9415313
    [Abstract] [Full Text] [Related]

  • 24. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP, Sauter BV, Huang TG, Meseck M, Woo SL, Chen SH.
    Gene Ther; 2005 Oct 10; 12(20):1526-33. PubMed ID: 15973445
    [Abstract] [Full Text] [Related]

  • 25. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer.
    Nakamori M, Iwahashi M, Nakamura M, Ueda K, Zhang X, Yamaue H.
    Clin Cancer Res; 2003 Jun 10; 9(6):2357-65. PubMed ID: 12796406
    [Abstract] [Full Text] [Related]

  • 26. Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy.
    Tosch C, Geist M, Ledoux C, Ziller-Remi C, Paul S, Erbs P, Corvaia N, Von Hoegen P, Balloul JM, Haegel H.
    Cancer Gene Ther; 2009 Apr 10; 16(4):310-9. PubMed ID: 18949016
    [Abstract] [Full Text] [Related]

  • 27. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.
    Wang Q, Yu H, Ju DW, He L, Pan JP, Xia DJ, Zhang LH, Cao X.
    Gene Ther; 2001 Apr 10; 8(7):542-50. PubMed ID: 11319621
    [Abstract] [Full Text] [Related]

  • 28. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B, Simmons A, Du T, Lin C, Moskalenko M, Gonzalez-Edick M, VanRoey M, Jooss K.
    Clin Immunol; 2009 Nov 10; 133(2):184-97. PubMed ID: 19664962
    [Abstract] [Full Text] [Related]

  • 29. Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.
    Kudo-Saito C, Schlom J, Hodge JW.
    Clin Cancer Res; 2005 Mar 15; 11(6):2416-26. PubMed ID: 15788693
    [Abstract] [Full Text] [Related]

  • 30. Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity.
    Mukhopadhaya A, Mendecki J, Dong X, Liu L, Kalnicki S, Garg M, Alfieri A, Guha C.
    Cancer Res; 2007 Aug 15; 67(16):7798-806. PubMed ID: 17699785
    [Abstract] [Full Text] [Related]

  • 31. Immune-mediated anti-neoplastic effect of intratumoral RSV envelope glycoprotein expression is related to apoptotic death of tumor cells but not to the size of syncytia.
    Hoffmann D, Grunwald T, Bayer W, Wildner O.
    World J Gastroenterol; 2008 Mar 28; 14(12):1842-50. PubMed ID: 18350621
    [Abstract] [Full Text] [Related]

  • 32. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J, Wu JH, Bouganim N, Galipeau J.
    Cancer Res; 2004 Dec 15; 64(24):8795-9. PubMed ID: 15604233
    [Abstract] [Full Text] [Related]

  • 33. Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy.
    Ahmed A, Jevremovic D, Suzuki K, Kottke T, Thompson J, Emery S, Harrington K, Bateman A, Vile R.
    Gene Ther; 2003 Sep 15; 10(19):1663-71. PubMed ID: 12923565
    [Abstract] [Full Text] [Related]

  • 34. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
    Li B, VanRoey M, Wang C, Chen TH, Korman A, Jooss K.
    Clin Cancer Res; 2009 Mar 01; 15(5):1623-34. PubMed ID: 19208793
    [Abstract] [Full Text] [Related]

  • 35. Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer.
    Hoffmann D, Bangen JM, Bayer W, Wildner O.
    Gene Ther; 2006 Nov 01; 13(21):1534-44. PubMed ID: 16791286
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H, Kishida T, Asada H, Shin-Ya M, Shinomiya T, Imanishi J, Shimada T, Nakai S, Takeuchi M, Hisa Y, Mazda O.
    J Gene Med; 2006 Jan 01; 8(1):90-9. PubMed ID: 16097036
    [Abstract] [Full Text] [Related]

  • 37. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.
    Toda M, Iizuka Y, Kawase T, Uyemura K, Kawakami Y.
    Cancer Gene Ther; 2002 Apr 01; 9(4):356-64. PubMed ID: 11960286
    [Abstract] [Full Text] [Related]

  • 38. A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model.
    Emtage PC, Wan Y, Bramson JL, Graham FL, Gauldie J.
    J Immunol; 1998 Mar 01; 160(5):2531-8. PubMed ID: 9498799
    [Abstract] [Full Text] [Related]

  • 39. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M, Mian A, Barber GN.
    Cancer Res; 2003 Dec 01; 63(23):8366-76. PubMed ID: 14678998
    [Abstract] [Full Text] [Related]

  • 40. Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model.
    Satoh T, Saika T, Ebara S, Kusaka N, Timme TL, Yang G, Wang J, Mouraviev V, Cao G, Fattah el MA, Thompson TC.
    Cancer Res; 2003 Nov 15; 63(22):7853-60. PubMed ID: 14633713
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.